Joao Gamelas Magalhaes, PhD currently serves as Head of Immunology Research at Enterome, Paris. He earned his PhD in Immunology from the University Pierre et Marie Curie, Paris, France, for his work on host-pathogen interaction at the Institut Pasteur (2001-2006). He pursued postdoctoral studies at the University of Toronto,

Department of Immunology, Toronto, Canada delving into the role of NLR receptors on innate and adaptive immunity. Then, he joined the Institut Curie, Paris, France as senior scientist to explore immuno-oncology bridging fundamental immunology with therapeutic applications. In 2017, Joao transitioned to industry joining Horizon

Discovery in Cambridge, UK, where he applied his expertise in immuno-oncology to boost the company IO drug discovery efforts. He returned to Paris in 2018, to assume his current leadership role at Enterome, driving forward innovative immunotherapy research advancing new peptide-based immunotherapies from R&D into clinic. With a current focus
on translational system immunology, Joao brings a wealth of expertise and knowledge ranging from innate to adaptive immune responses applied to T cell-based therapies in cancer, allergies and auto-immune diseases.